ASRM Applauds Administration Decision to Continue Fetal Tissue Research
Apr 16, 2021
Published in: ASRM Press Release
“The American Society for Reproductive Medicine (ASRM) applauds the decision from the National Institutes of Health (NIH)to continue to allow federally funded researchers to work with tissues and cell lines originally derived from fetal tissue. As we have seen with the development of the COVID-19 vaccines and therapeutics, the impact of these materials as research tools is broad, and essential.
The United States government has developed a robust system of oversight and it important that this system be allowed to work as designed. Ideologically driven politicians must not be allowed to interfere with this system on a whim. Whether its fetal tissue, embryonic stem cells or CRSIPR, we have an unfortunate tendency to politicize scientific advances if they in any way touch on reproduction.”
For a copy of the NIH announcement click here.
For more information on these press releases, contact:
J. Benjamin Younger Office of Public Affairs
409 12th Street SW, Suite 602
Washington, DC 20024-2188
Tel: (202) 863-2494
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
Phone: 202-863-2494 or 202-421-5112 (mobile)